- Home
- APLD vs SPRY Comparison
APLD vs SPRY Comparison
Compare APLD & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLD
- SPRY
- Stock Information
- Founded
- APLD 2001
- SPRY 2015
- Country
- APLD United States
- SPRY United States
- Employees
- APLD N/A
- SPRY N/A
- Industry
- APLD Investment Bankers/Brokers/Service
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- APLD Finance
- SPRY Health Care
- Exchange
- APLD Nasdaq
- SPRY Nasdaq
- Market Cap
- APLD 1.3B
- SPRY 1.4B
- IPO Year
- APLD N/A
- SPRY N/A
- Fundamental
- Price
- APLD $5.61
- SPRY $11.68
- Analyst Decision
- APLD Strong Buy
- SPRY Strong Buy
- Analyst Count
- APLD 9
- SPRY 4
- Target Price
- APLD $10.67
- SPRY $28.75
- AVG Volume (30 Days)
- APLD 35.3M
- SPRY 1.3M
- Earning Date
- APLD 04-14-2025
- SPRY 05-14-2025
- Dividend Yield
- APLD N/A
- SPRY N/A
- EPS Growth
- APLD N/A
- SPRY N/A
- EPS
- APLD N/A
- SPRY N/A
- Revenue
- APLD $221,192,000.00
- SPRY $97,122,000.00
- Revenue This Year
- APLD $32.84
- SPRY $1.49
- Revenue Next Year
- APLD N/A
- SPRY $141.68
- P/E Ratio
- APLD N/A
- SPRY N/A
- Revenue Growth
- APLD 53.70
- SPRY 971120.00
- 52 Week Low
- APLD $3.01
- SPRY $7.55
- 52 Week High
- APLD $12.48
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- APLD 56.02
- SPRY 35.81
- Support Level
- APLD $5.24
- SPRY $11.80
- Resistance Level
- APLD $6.28
- SPRY $14.00
- Average True Range (ATR)
- APLD 0.40
- SPRY 0.65
- MACD
- APLD 0.18
- SPRY -0.28
- Stochastic Oscillator
- APLD 74.03
- SPRY 11.67
About APLD Applied Digital Corporation
Applied Digital Corp is a designer, developer, and operator of next-generation digital infrastructure across North America. It provides digital infrastructure solutions and cloud services to industries like High-Performance Computing (HPC) and Artificial Intelligence (AI). The company operates in the following business segments; Data Center Hosting Business, Cloud Services Business, and HPC Hosting Business. The majority of its revenue is generated from the Data Center Hosting Business which operates data centers to provide energized space to crypto mining customers.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.